JP2010540424A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540424A5
JP2010540424A5 JP2010525426A JP2010525426A JP2010540424A5 JP 2010540424 A5 JP2010540424 A5 JP 2010540424A5 JP 2010525426 A JP2010525426 A JP 2010525426A JP 2010525426 A JP2010525426 A JP 2010525426A JP 2010540424 A5 JP2010540424 A5 JP 2010540424A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
hydrogen
compound according
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010525426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540424A (ja
Filing date
Publication date
Priority claimed from GBGB0718432.8A external-priority patent/GB0718432D0/en
Application filed filed Critical
Publication of JP2010540424A publication Critical patent/JP2010540424A/ja
Publication of JP2010540424A5 publication Critical patent/JP2010540424A5/ja
Pending legal-status Critical Current

Links

JP2010525426A 2007-09-21 2008-09-19 チエノピリミジン化合物類および組成物 Pending JP2010540424A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0718432.8A GB0718432D0 (en) 2007-09-21 2007-09-21 New chemical compounds
PCT/GB2008/003180 WO2009037468A1 (en) 2007-09-21 2008-09-19 Thienopyrimidine compounds and compositions

Publications (2)

Publication Number Publication Date
JP2010540424A JP2010540424A (ja) 2010-12-24
JP2010540424A5 true JP2010540424A5 (enExample) 2011-11-04

Family

ID=38670287

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010525426A Pending JP2010540424A (ja) 2007-09-21 2008-09-19 チエノピリミジン化合物類および組成物

Country Status (5)

Country Link
US (1) US8354415B2 (enExample)
EP (1) EP2207780B1 (enExample)
JP (1) JP2010540424A (enExample)
GB (1) GB0718432D0 (enExample)
WO (1) WO2009037468A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011157168A (ja) 2010-01-29 2011-08-18 Tokyo Kikai Seisakusho Ltd 新聞製作装置
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
RU2637925C2 (ru) 2012-01-10 2017-12-08 Ф. Хоффманн-Ля Рош Аг Соединения тиенопиримидина
BR112016007238A2 (pt) 2013-10-07 2017-08-01 Bayer Pharma AG tienouracilcarboxamidas cíclicas e sua utilização
UY36586A (es) 2015-03-26 2016-10-31 Bayer Pharma AG Heterociclilmetiltienouracilos y uso de los mismos
WO2018013611A1 (en) 2016-07-11 2018-01-18 Corvus Pharmaceuticals, Inc. Anti-cd73 antibodies
WO2018041771A1 (de) 2016-09-02 2018-03-08 Bayer Pharma Aktiengesellschaft (1-methylcyclopropyl)methyl-substituierte thienouracile und ihre verwendung
KR20190053242A (ko) 2016-09-23 2019-05-17 바이엘 악티엔게젤샤프트 N3-시클릭 치환된 티에노우라실 및 그의 용도
AU2018325451A1 (en) * 2017-08-31 2020-03-05 Corvus Pharmaceuticals, Inc. Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
EP3575287A1 (en) * 2018-05-31 2019-12-04 Universiteit Leiden Inhibitors of n-acylphosphatidylethanolamine phospholipase d (nape-pld)
KR20250004779A (ko) 2022-04-13 2025-01-08 길리애드 사이언시즈, 인코포레이티드 Trop-2 발현 암을 치료하기 위한 병용 요법
WO2025137640A1 (en) 2023-12-22 2025-06-26 Gilead Sciences, Inc. Azaspiro wrn inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915437D0 (en) * 1999-07-01 1999-09-01 Cerebrus Ltd Chemical compounds III
EP1467995B1 (en) * 2001-12-20 2010-05-19 OSI Pharmaceuticals, Inc. Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
CN1890241A (zh) * 2003-10-31 2007-01-03 Cv医药有限公司 A2b腺苷受体拮抗剂
CA2644996A1 (en) * 2006-03-02 2007-09-13 Cv Therapeutics, Inc. A2a adenosine receptor antagonists

Similar Documents

Publication Publication Date Title
JP2010540424A5 (enExample)
AU2017302635B2 (en) Chemokine receptor modulators and uses thereof
JP2009507030A5 (enExample)
JP2016530213A5 (enExample)
JP2017523167A5 (enExample)
JP2019515908A5 (enExample)
JP2004525179A5 (enExample)
JP2012502099A5 (enExample)
TW201011003A (en) Triazole compounds that modulate HSP90 activity
JP2009530345A5 (enExample)
JP2009542716A5 (enExample)
JP2010510234A5 (enExample)
JP2009502743A5 (enExample)
JP2007519649A5 (enExample)
JP2016515561A5 (enExample)
JP2010510233A5 (enExample)
MX2010002278A (es) Farmacos antivirales para el tratamiento de una infeccion por arenavirus.
JP2019526596A5 (enExample)
JP2012509263A5 (enExample)
JP2006517939A5 (enExample)
JP2008533007A5 (enExample)
JP2014510147A5 (enExample)
JP2007516205A5 (enExample)
JP2008500999A5 (enExample)
JP2013537198A5 (enExample)